Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences
Get Alerts ORCL Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
Revenue Growth %: +27.5%
Join SI Premium – FREE
Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies
Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics
NASHVILLE, Tenn.,
"Oracle continues to deliver game-changing products that modernize and enhance clinical research and tighten the connection between bench and bedside," said
Supported by a wide variety of real-world data sources, such as CancerMPact and multiomics, the platform delivers actionable insights out of the box with pre-built curated datasets, data pipelines, adaptable models, and analytics for determining patient experience, safety monitoring, therapy effectiveness, and brand measurement. Oracle Analytics Intelligence for Life Sciences customers who use the Oracle Learning Health Network will also have continuously updated anonymized Oracle Real World Data (ORWD) available in their analytics environment, which broadens their access to even more information.
Oracle Analytics Intelligence for Life Sciences is powered by Oracle Health Data Intelligence (HDI). Built on the security and high performance of Oracle Cloud Infrastructure (OCI), Oracle Health Data Intelligence integrates, secures, and analyzes data from a broad range of sources including electronic health records (EHR), enterprise applications, insurance claims, and demographic records, to provide a more comprehensive view of individual patients and overall population health.
This proven, EHR-agnostic platform is a continuously learning ecosystem that powers provider applications to support intelligent clinical decision-making, care coordination, and value-based care delivery. With Oracle Analytics Intelligence for Life Sciences, Oracle is now extending this platform to enable clinical research and insight generation, which feeds back into the HDI ecosystem in a continuous learning loop.
The platform was developed in coordination with Oracle's globally renowned Research Services division, merging cutting-edge technology with deep domain expertise. This collaboration brings together top life sciences experts, including the oncology researchers behind CancerMPact, to deliver a groundbreaking platform that advances insights and therapies with unmatched speed and precision.
For more information about Oracle Analytics Intelligence for Life Sciences visit: https://www.oracle.com/life-sciences/
To join segments of the Oracle Health Summit virtually, visit: https://www.oracle.com/health/health-summit/
About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the life sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences
About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.
Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.
View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-launches-ai-powered-oracle-analytics-intelligence-for-life-sciences-302291197.html
SOURCE Oracle
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hozpitality Celebrates Hospitality Excellence at the Middle East Chef Excellence Awards, F&B Excellence Awards and Leaders Powerlist 2026
- New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple my
- Software stocks tumble in sympathy as fragile market sentiment fractures again
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share